Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperplasia (BPH)

NCT01460342 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

610

Enrollment

INDUSTRY

Sponsor class

Conditions

Benign Prostatic Hyperplasia

Interventions

DRUG: Tadalafil
DRUG: Placebo

Sponsor

Eli Lilly and Company